Die Olympus Corporation hat bekannt gegeben, dass das Board of Directors vorläufig beschlossen hat, die Führungskräfte wie unten beschrieben zu verändern. Der Beschluss soll im März 2024 formell im Board of Directors gefasst werden und am 1. April 2024 in Kraft treten. Der Grund für die Änderung ist die weitere Stärkung der Managementstruktur auf der Grundlage eines Nachfolgeplans. Seiji Kuramoto, Corporate Officer und Co-Head der Therapeutic Solutions Division, als Executive Officer und Leiter der Therapeutic Solutions Division. Tatsuya Izumi als Executive Officer und Chief Financial Officer. Boris Shkolnik, Global Functional Head of Quality, als Executive Officer und Chief Quality Officer. Gabriela Kaynor bleibt als Executive Officer und übernimmt die Rolle des Chief Strategy Officer. Ausscheidende Executive Officers: Chikashi Takeda als Executive Officer und Chief Financial Officer; Nacho Abia als Executive Officer und Chief Strategy Officer; Pierre Boisier als Executive Officer und Chief Quality Officer. Seiji Kuramoto Karriereübersicht: April 1988 Eintritt in die Olympus Corporation; April 2005 Vice President, Olympus Surgical & Industrial America Inc.; April 2008 Executive Director, Olympus America Inc.April 2009 General Manager of Marketing for Surgical, Olympus Medical Systems; Mai 2013 General Manager of Product Planning, Sony Olympus Medical Solutions; Juli 2017 Executive Vice President und Representative Director, Sony Olympus Medical Solutions; April 2020 Senior Vice President, Endoscopic Solution GI Business Leader, Global, Olympus Corporation Senior Vice President, Endoscopic Solution Surgical Business Leader, Global, Olympus Corporation Director, Sony Olympus Medical Solutions; April 2021 Therapeutic Solutions Division Co-Head, Olympus Corporation (present); April 2022 Corporate Officer, Olympus Corporation (present); April 2024 Executive Officer and Therapeutic Solutions Division Head, Olympus Corporation (Plan). Tatsuya Izumi Karriereübersicht: April 1987 Eintritt in die ITOCHU Corporation; Mai 2006 General Manager, Planning & Control Department, Finance Division, ITOCHU Corporation; Mai 2010 Treasurer & General Manager, Finance Division, ITOCHU International Inc.April 2013 CFO, ASEAN & South West Asia Bloc, ITOCHU Corporation; Mai 2016 CFO, Textile Company, ITOCHU Corporation; April 2019 Executive Officer, General Manager, General Accounting Control Division, ITOCHU Corporation; Mai 2021 Director, Managing Executive Officer, Chief Executive of Administration, NIPPON ACCESS, INC.; April 2022 Director, Senior Managing Executive Officer, Chief Executive of Administration, NIPPON ACCESS, INC.; April 2024 Executive Officer und Chief Financial Officer, Olympus Corporation (Plan). Boris Shkolnik Zusammenfassung seiner Karriere: März 1993 Eintritt bei Cordis; Februar 2003 Manager, Plant Quality Assurance, Cordis; März 2005 Senior Director, Quality Management, Becton, Dickinson and Company; August 2011 Worldwide Vice President, Quality Management, Becton, Dickinson and Company; August 2019 Senior Vice President, Quality Management, Medical Segment, Becton, Dickinson and Company; Februar 2022 Eintritt in die Olympus Corporation of the Americas Senior Vice President, Product Quality, Olympus Corporation; April 2023 Global Functional Head of Quality, Olympus Corporation (derzeit) Director, Olympus Medical Systems Corporation (derzeit); April 2024 Executive Officer und Chief Quality Officer, Olympus Corporation (Plan). Neues Management-Team ab 1. April 2024 Yasuo Takeuchi als Director, Representative Executive Officer und Executive Chairman und ESG Officer; Stefan Kaufmann als Director, Representative Executive Officer, President und Chief Executive Officer;
Frank Drewalowski als Executive Officer und Leiter des Geschäftsbereichs Endoscopic Solutions; Seiji Kuramoto als Executive Officer und Leiter des Geschäftsbereichs Therapeutic Solutions; Tatsuya Izumi Executive Officer und Chief Financial Officer; Gabriela Kaynor Executive Officer und Chief Strategy Officer; Tetsuo Kobayashi Executive Officer und Chief Manufacturing and Supply Officer; André Roggan Executive Officer und Chief Technology Officer; Boris Shkolnik Executive Officer und Chief Quality Officer; Shigeto Ohtsuki Executive Officer und Chief Human Resources Officer.